The Global Veterinary Vaccines Market to Grow at 6.68% CAGR by 2028 - PowerPoint PPT Presentation

About This Presentation

The Global Veterinary Vaccines Market to Grow at 6.68% CAGR by 2028


The Global Veterinary Vaccines Market is anticipated to witness growth with a CAGR of 7.46% during the forecast period of 2022-2028. Get a Free Sample Report. – PowerPoint PPT presentation

Number of Views:9


Transcript and Presenter's Notes

Title: The Global Veterinary Vaccines Market to Grow at 6.68% CAGR by 2028

The Global Veterinary Vaccines Market to Grow at
6.68 CAGR by 2028
  • Triton Market Research presents the Global
    Veterinary Vaccines Market report segmented by
    Animal Type (Companion Animals Canine, Feline,
    Equine, Livestock Animals Cattle, Pigs,
    Poultry, Sheep, Other Livestock Animals,
    Aquaculture), by Disease Type (Aquaculture
    Disease, Poultry Disease, Canine Disease, Bovine
    Disease, Porcine Disease, Other Disease Types),
    by Product Type (Inactivated Vaccines, Toxoid
    Vaccines, Subunit Vaccines, Attenuated Vaccines,
    DNA Vaccines, Conjugate Vaccines, Recombinant
    Vaccines), by Regional Outlook (North America,
    Europe, Asia-Pacific, Latin America, Middle East
    and Africa).
  • It also discusses the Market Summary, Industry
    Outlook, Key Insights, Porters Five Forces
    Analysis, Market Attractiveness Index, Value
    Chain Analysis, Key Buying Criteria, Regulatory
    Framework, Vendor Scorecard, Key Market
    Strategies, Drivers, Challenges, Opportunities,
    Competitive Landscape, Research Methodology
    Scope, Global Market Size, Forecasts Analysis
  • Triton Market Research has put forth that the
    Global Veterinary Vaccines Market would evolve at
    a CAGR of 7.46 over the estimated period 2022 to

Request Free Sample Report https//www.tritonmark
The demand for companion animals is rising,
especially among the urban population. Animals
such as cats and dogs are in high demand, as some
people are genuinely fond of them and treat their
pets as family members. These animals are highly
prone to developing diseases, which makes it
important to administer them vaccines. The
increasing adoption of companion animals is thus
expected to offer lucrative growth opportunities
for the adoption of veterinary vaccines. However,
the shortage of skilled veterinarians and animal
health professionals, who can diagnose diseases
and provide effective solutions like vaccines is
hindering the growth of the studied market. The
Asia-Pacific region is expected to showcase the
fastest growth in the global market over the
considered period. In May 2021, the Association
of Southeast Asian Nations (ASEAN) and the World
Organization for Animal Health (OIE) signed a new
MoU in a bid to strengthen their bond and further
support the prevention, control, and eradication
of animal diseases in the region. Their regional
animal disease control programs include classical
swine fever, African swine fever, and peste des
petits ruminants (PPR). Initiatives such as this
are fostering the growth of the market in the
APAC. Boehringer Ingelheim International GmbH,
Vaxxinova GmbH, Elanco Animal Health Inc, Zoetis
Inc, Virbac SA, Hester Biosciences Ltd, Indian
Immunologicals Limited, Ceva Sante Animale,
Brilliant Bio Pharma, Merck Animal Health, Hipra,
and Phibro Animal Health are some of the dominant
companies in this market. The market is largely
dominated by the established players. Thus,
aspiring players need to focus on innovation,
RD, expanding business operations, etc., to gain
a competitive edge, which is capital- intensive.
Though there are startups operating in this
market, the only way to grow is by creating niche
products beneficial to the market. Industry
rivalry among the leading names is high as the
market has a wide scope globally, which is also a
lucrative opportunity for companies to monetize
Contact Us Phone
44 7441 911839
Write a Comment
User Comments (0)